Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Atrophic vulvovaginitis
ADR ID BADD_A00380
ADR Hierarchy
21      Reproductive system and breast disorders
21.02      Menopause related conditions
21.02.01      Menopausal effects on the genitourinary tract
21.02.01.003      Atrophic vulvovaginitis
Description Inflammation of the vagina due to thinning of the vaginal wall and decreased lubrication associated with reduced estrogen levels at MENOPAUSE. [MeSH]
MedDRA Code 10003693
MeSH ID D059268
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Atrophic vaginitis | Atrophic vulva | Atrophic vulvitis | Atrophic vulvovaginitis | Atrophy of vulva | Postmenopausal atrophic vaginitis | Senile vaginitis | Vaginitis atrophic | Vaginitis atropic | Vulval atrophic | Vulvovaginal atrophy | Vulvovaginitis atrophic | Vulvovaginitis atrophy | Atrophic Vaginitis | Atrophic Vaginitides | Vaginitides, Atrophic | Vaginitis, Atrophic
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00036Acitretin--
BADD_D00066Alendronic acid0.001819%
BADD_D00142Anastrozole0.000754%
BADD_D00424Cevimeline--
BADD_D00425Cevimeline hydrochloride--
BADD_D00528Conjugated estrogens0.001556%
BADD_D00809Escitalopram--
BADD_D01142Imiquimod--
BADD_D01209Isosorbide--
BADD_D01211Isosorbide mononitrate--
BADD_D01281Levonorgestrel0.002085%
BADD_D01956Rivastigmine tartrate--
BADD_D02010Sertraline--
BADD_D02011Sertraline hydrochloride--
BADD_D02446Prasterone0.008727%
The 1th Page    1    Total 1 Pages